Fundraising FoxBioGenerator Ventures — 2025 Investments
5 investments dated 2025 · listed companies and verified rows first · show all
Buck Surgical develops surgical technologies aimed at improving outcomes for complex procedures and expanding patient access to reconstructive and limb-preserving treatments.
HardwareHealthtechMedical DevicesSt. Louis, US
Donald W. Buck II(Founder)inDonald Buck(Executive Officer, Director)
Co-investorsCentennial InvestorsMissouri Technology Corporation
C2N Diagnostics develops and commercializes blood-based diagnostic tests for Alzheimer's disease and other neurodegenerative conditions, using proprietary LC-MS/MS mass spectrometry to detect brain amyloid pathology.
BiotechDigital HealthMedical DevicesSt. Louis, US
Dr. David Holtzman(Director)Dr. Randall Bateman(Director)Dr. Joel Braunstein(Executive Officer, Director)Micah Onixt(Executive Officer)
BoardDr. Michael Goldblatt(Director)
Neurolutions makes IpsiHand, an FDA-cleared brain-computer interface system for at-home motor rehabilitation of chronic stroke survivors with arm and hand weakness.
BiotechDigital HealthHealthtechMedical DevicesVan Nuys, US
Eric Leuthardt(Director)inLeo Petrossian(Executive Officer, Director)in
BoardYuanwei Tai(Director)Kevin Reilly(Director)inFred Khosravi(Director)inStavros Vizirgianakis(Director)
Co-investorsExcelestar VenturesAlly Bridge GroupAmed Ventures
Plastomics develops trait delivery technology for agriculture using cell biology, plant tissue culture, transformation, and molecular biology methods.
AgTechBiotechSt. Louis, US
Jeffrey Staub(Executive Officer, Director)inElizabeth Gallegos(Executive Officer)in
BoardMartha Schlicher(Executive Officer, Director)inBrian Clevinger(Director)Charles Bolten(Director)Dave Duncan(Director)
Co-investorsArgonautic VenturesCentennial InvestorsFulcrum Global CapitaliSelect FundMissouri Technology CorporationRevolution+2 more
SweetSpot provides a remote diabetes monitoring and management platform that improves data accessibility for clinicians and supports patients using diabetes technology such as CGMs and insulin pumps.
Digital HealthHealthtechMedical DevicesSaaS
Stephen Von Rump(Chief Executive Officer)inRalph Oiknine(Chief Medical Officer)Abigail Cohen(Chief Commercial Officer)inAmiad Fredman(Chief Product Officer)in
Co-investorsMissouri Technology CorporationCultivation Capital
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.